Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

New appointment at Premier Research Group

This article was originally published in Scrip

Executive Summary

Premier Research Group (US) has appointed Dr Fabio Trave executive director of medical affairs and strategic product development. He will be based in the company's Milan office. Dr Trave has extensive experience working for both North American and European-based pharmaceutical companies, including Farmitalia Carlo Erba, Warner Lambert Parke-Davis, Pharmacia and Bristol-Myers Squibb, where he was most recently responsible for pharmacovigilance activities in Europe, Middle East, and Africa.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

SC031574

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel